{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:45:31Z","timestamp":1788482731340,"version":"build-2803163510"},"reference-count":106,"publisher":"Informa UK Limited","issue":"7","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Sci. OA"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.2144\/fsoa-2022-0081","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T14:55:36Z","timestamp":1685631336000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Ocular Complications of Antineoplastic Therapies"],"prefix":"10.1080","volume":"9","author":[{"given":"Abbas","family":"Bader","sequence":"first","affiliation":[{"name":"University of Missouri Kansas City School of Medicine, 5000 Holmes St, Kansas City, MO, 64110, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Begemann","sequence":"additional","affiliation":[{"name":"Saint Luke's Hospital of Kansas City, 4401 Wornall Rd, Kansas City, MO, 64111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Al-Obaidi","sequence":"additional","affiliation":[{"name":"Saint Luke's Hospital of Kansas City, 4401 Wornall Rd, Kansas City, MO, 64111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1353-4437","authenticated-orcid":false,"given":"Muhammad Hamza","family":"Habib","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute of New Jersey, 195 Little Albany St, New Brunswick, NJ, 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6914-7439","authenticated-orcid":false,"given":"Faiz","family":"Anwer","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-2265","authenticated-orcid":false,"given":"Shahzad","family":"Raza","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Taussig Cancer Institute, 9500 Euclid Avenue, Cleveland, OH, 44195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/543531"},{"issue":"4","key":"e_1_3_3_4_1","first-page":"97","article-title":"Cisplatin-Based Chemotherapy of Human Cancers","volume":"11","author":"Brown A","year":"2019","unstructured":"BrownA , KumarS , TchounwouPB. Cisplatin-Based Chemotherapy of Human Cancers. J. Cancer Sci. Ther.11(4), 97 (2019).","journal-title":"J. Cancer Sci. Ther."},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S65774"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.12.1683"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1997.tb00280.x"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(81)90155-4"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1983.1.6.392"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(99)00250-6"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a058497"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.8.1120"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.07.046"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612805666230110214512"},{"issue":"6","key":"e_1_3_3_15_1","first-page":"709","article-title":"Ocular complications in high-dose chemoradiotherapy and marrow transplantation","volume":"13","author":"Jack MK","year":"1981","unstructured":"JackMK , HicksJD. Ocular complications in high-dose chemoradiotherapy and marrow transplantation. Ann. Ophthalmol.13(6), 709\u2013711 (1981).","journal-title":"Ann. Ophthalmol."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197907)44:1<69::AID-CNCR2820440113>3.0.CO;2-O"},{"issue":"6","key":"e_1_3_3_17_1","first-page":"438","article-title":"Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer","volume":"13","author":"Stevens A","year":"2001","unstructured":"StevensA , SpoonerD. Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer. Clin. Oncol. (R. Coll. Radiol.).13(6), 438\u2013440 (2001).","journal-title":"Clin. Oncol. (R. Coll. Radiol.)."},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1982.01030040746007"},{"issue":"4","key":"e_1_3_3_19_1","first-page":"261","article-title":"Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine)","volume":"1","author":"Grimson BS","year":"1981","unstructured":"GrimsonBS , MahaleyMSJr , DubeyHD , DudkaL. Ophthalmic and central nervous system complications following intracarotid BCNU (Carmustine). J Clin. Neuroophthalmol.1(4), 261\u2013264 (1981).","journal-title":"J Clin. Neuroophthalmol."},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950050134"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701913"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(86)33544-9"},{"issue":"3","key":"e_1_3_3_23_1","first-page":"409","volume":"19","author":"Nakamura T","year":"1992","unstructured":"NakamuraT , UedaT , UchidaM. Gan To Kagaku Ryoho.19(3), 409\u2013420 (1992).","journal-title":"Gan To Kagaku Ryoho."},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830201)51:3<430::AID-CNCR2820510313>3.0.CO;2-5"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197701)39:1<58::AID-CNCR2820390111>3.0.CO;2-5"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19911015)68:8<1691::AID-CNCR2820680805>3.0.CO;2-W"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.4274\/tjo.galenos.2020.99248"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules13081551"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1992.01080200130040"},{"issue":"4","key":"e_1_3_3_30_1","first-page":"580","article-title":"5-Fluorouracil toxicity to the ocular surface epithelium","volume":"26","author":"Shapiro MS","year":"1985","unstructured":"ShapiroMS , ThoftRA , FriendJ , ParrishRK , GresselMG. 5-Fluorouracil toxicity to the ocular surface epithelium. Invest. Ophthalmol. Vis. Sci.26(4), 580\u2013583 (1985).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01203288"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.IOP.0000066648.33513.3D"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000487474"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219886640"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1979.tb04317.x"},{"key":"e_1_3_3_36_1","first-page":"95","article-title":"Necrotizing uveitis incident to perfusion of intractraial malignancies with nitrogen mustard or related compounds","volume":"58","author":"Anderson B","year":"1960","unstructured":"AndersonBJr. Necrotizing uveitis incident to perfusion of intractraial malignancies with nitrogen mustard or related compounds. Trans. Am. Ophthalmol. Soc.58, 95\u2013104 (1960).","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1359::AID-CNCR1>3.0.CO;2-G"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262591"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363190-00013"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009073431015"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04337-8"},{"issue":"10","key":"e_1_3_3_42_1","first-page":"1225","article-title":"Central nervous system toxicity of fludarabine phosphate","volume":"70","author":"Chun HG","year":"1986","unstructured":"ChunHG , Leyland-JonesBR , CarykSM , HothDF. Central nervous system toxicity of fludarabine phosphate. Cancer Treat Rep.70(10), 1225\u20131228 (1986).","journal-title":"Cancer Treat Rep."},{"key":"e_1_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000571"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1521-6926(03)00002-1"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<1999::AID-CNCR2820491009>3.0.CO;2-B"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/86.14.1099"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ICL.0000062464.79558.5A"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.1.101"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0801-5"},{"key":"e_1_3_3_50_1","volume-title":"StatPearls [Internet].","author":"Thomson RJ","year":"2023","unstructured":"ThomsonRJ , MoshirfarM , RonquilloY. Tyrosine Kinase Inhibitors. In: StatPearls [Internet].StatPearls Publishing, FL, USA (2023)."},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2010.04.016"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/357027"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.26658"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1089\/108076803322279426"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S8521"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552211060730"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231877"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-021-00305-9"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/08164622.2022.2086792"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-09-739086"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1285-9"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000412"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1841802"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211001268"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1400376"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17634"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071823"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2014.07.003"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22101551"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0096-1"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2015.82"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002451"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0541-0"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.01.007"},{"key":"e_1_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2018-0608"},{"key":"e_1_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2021.045"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0367"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002181"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00944"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/734249"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03492.x"},{"issue":"2","key":"e_1_3_3_82_1","first-page":"216","article-title":"Erlotinib-induced episcleritis in a patient with pancreatic cancer","volume":"9","author":"Shahrokni A","year":"2008","unstructured":"ShahrokniA , MatuszczakJ , RajebiMR , SaifMW. Erlotinib-induced episcleritis in a patient with pancreatic cancer. JOP.9(2), 216\u2013219 (2008).","journal-title":"JOP."},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1354"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00592-3"},{"key":"e_1_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.678634"},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.18773\/austprescr.2016.053"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00002"},{"key":"e_1_3_3_88_1","doi-asserted-by":"crossref","first-page":"e000331","DOI":"10.1136\/bmjophth-2019-000331","article-title":"Ocular side effects of antirheumatic medications: a qualitative review","volume":"5","author":"Castillejo Becerra C M","year":"2020","unstructured":"MCastillejo Becerra C , DingY , KenolB , HendershotA , MearaAS. Ocular side effects of antirheumatic medications: a qualitative review. BMJ Open Ophthalmology5, e000331 (2020).","journal-title":"BMJ Open Ophthalmology"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.2.317"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-019-01136-x"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-320814"},{"issue":"7","key":"e_1_3_3_92_1","first-page":"3636","article-title":"CAR T-Cell Therapy Associated Ocular Adverse Events Reported to the Food and Drug Administration","volume":"61","author":"Andrew Fischer","year":"2020","unstructured":"AndrewFischer , AlbertLi. CAR T-Cell Therapy Associated Ocular Adverse Events Reported to the Food and Drug Administration. Invest. Ophthalmol. Vis. Sci.61(7), 3636 (2020).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2018.01.004"},{"key":"e_1_3_3_94_1","volume-title":"StatPearls [Internet].","author":"Sharma A","year":"2023","unstructured":"SharmaA , PreussCV. Bortezomib. [Updated 2022 Sep 21]. In: StatPearls [Internet].StatPearls Publishing, FL, USA (2023)."},{"key":"e_1_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1118-x"},{"key":"e_1_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.04.013"},{"key":"e_1_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318166f483"},{"key":"e_1_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1159\/000444047"},{"key":"e_1_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1188\/16.ONF.235-243"},{"key":"e_1_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817323"},{"key":"e_1_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1159\/000511340"},{"key":"e_1_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3550"},{"key":"e_1_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu169"},{"key":"e_1_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-016-3019-5"},{"key":"e_1_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw100"},{"key":"e_1_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/857519"},{"key":"e_1_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920615)69:12<2961::AID-CNCR2820691215>3.0.CO;2-W"},{"key":"e_1_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO;2-I"}],"container-title":["Future Science OA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2144\/fsoa-2022-0081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:48:36Z","timestamp":1719125316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2144\/fsoa-2022-0081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":106,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.2144\/fsoa-2022-0081"],"URL":"https:\/\/doi.org\/10.2144\/fsoa-2022-0081","relation":{},"ISSN":["2056-5623"],"issn-type":[{"value":"2056-5623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"FSO871"}}